277 related articles for article (PubMed ID: 38383408)
1. Sex-specific modulation of early life vocalization and cognition by Fmr1 gene dosage in a mouse model of Fragile X Syndrome.
Giua G; Iezzi D; Caceres-Rodriguez A; Strauss B; Chavis P; Manzoni OJ
Biol Sex Differ; 2024 Feb; 15(1):18. PubMed ID: 38383408
[TBL] [Abstract][Full Text] [Related]
2. Characterization of ultrasonic vocalizations of Fragile X mice.
Belagodu AP; Johnson AM; Galvez R
Behav Brain Res; 2016 Sep; 310():76-83. PubMed ID: 27142239
[TBL] [Abstract][Full Text] [Related]
3. Reversal of ultrasonic vocalization deficits in a mouse model of Fragile X Syndrome with minocycline treatment or genetic reduction of MMP-9.
Toledo MA; Wen TH; Binder DK; Ethell IM; Razak KA
Behav Brain Res; 2019 Oct; 372():112068. PubMed ID: 31271818
[TBL] [Abstract][Full Text] [Related]
4. Temporal and spectral differences in the ultrasonic vocalizations of fragile X knock out mice during postnatal development.
Lai JK; Sobala-Drozdowski M; Zhou L; Doering LC; Faure PA; Foster JA
Behav Brain Res; 2014 Feb; 259():119-30. PubMed ID: 24211451
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of ultrasonic vocalizations in a mouse model of fragile X syndrome reveals limited, call type specific deficits.
Roy S; Watkins N; Heck D
PLoS One; 2012; 7(9):e44816. PubMed ID: 22984567
[TBL] [Abstract][Full Text] [Related]
6. Spectral and temporal properties of calls reveal deficits in ultrasonic vocalizations of adult Fmr1 knockout mice.
Hodges SL; Nolan SO; Reynolds CD; Lugo JN
Behav Brain Res; 2017 Aug; 332():50-58. PubMed ID: 28552599
[TBL] [Abstract][Full Text] [Related]
7. Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.
Rotschafer SE; Trujillo MS; Dansie LE; Ethell IM; Razak KA
Brain Res; 2012 Feb; 1439():7-14. PubMed ID: 22265702
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific and genotype-specific differences in vocalization development in FMR1 knockout mice.
Reynolds CD; Nolan SO; Jefferson T; Lugo JN
Neuroreport; 2016 Dec; 27(18):1331-1335. PubMed ID: 27824730
[TBL] [Abstract][Full Text] [Related]
9. High-throughput analysis of vocalizations reveals sex-specific changes in Fmr1 mutant pups.
Nolan SO; Hodges SL; Lugo JN
Genes Brain Behav; 2020 Feb; 19(2):e12611. PubMed ID: 31587487
[TBL] [Abstract][Full Text] [Related]
10. Hyperexcitability in the Olfactory Bulb and Impaired Fine Odor Discrimination in the
Kuruppath P; Xue L; Pouille F; Jones ST; Schoppa NE
J Neurosci; 2023 Nov; 43(48):8243-8258. PubMed ID: 37788940
[TBL] [Abstract][Full Text] [Related]
11. A single episode of early-life status epilepticus impacts neonatal ultrasonic vocalization behavior in the Fmr1 knockout mouse.
Huebschman JL; Hodges SL; Reynolds CD; Nolan SO; Lugo JN
Epilepsy Behav; 2020 Oct; 111():107279. PubMed ID: 32693376
[TBL] [Abstract][Full Text] [Related]
12. Multiple Early-Life Seizures Alters Neonatal Communicative Behavior in Fmr1 Knockout Mice.
Nguyen PH; Narvaiz DA; Womble PD; Sullens DG; Binder MS; Hodges SL; Kwok E; Lugo JN
Dev Neurosci; 2022; 44(6):478-486. PubMed ID: 35512644
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Fmr1 in parvalbumin-expressing neurons results in dysregulated translation and selective behavioral deficits associated with fragile X syndrome.
Kalinowska M; van der Lei MB; Kitiashvili M; Mamcarz M; Oliveira MM; Longo F; Klann E
Mol Autism; 2022 Jun; 13(1):29. PubMed ID: 35768828
[TBL] [Abstract][Full Text] [Related]
14. Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.
Gaudissard J; Ginger M; Premoli M; Memo M; Frick A; Pietropaolo S
Autism Res; 2017 Oct; 10(10):1584-1596. PubMed ID: 28590057
[TBL] [Abstract][Full Text] [Related]
15. Perinatal supplementation with omega-3 fatty acids corrects the aberrant social and cognitive traits observed in a genetic model of autism based on FMR1 deletion in rats.
Schiavi S; Carbone E; Melancia F; Buzzelli V; Manduca A; Campolongo P; Pallottini V; Trezza V
Nutr Neurosci; 2022 May; 25(5):898-911. PubMed ID: 32912100
[No Abstract] [Full Text] [Related]
16. The Impact of Mild Chronic Stress and Maternal Experience in the
Subashi E; Lemaire V; Petroni V; Pietropaolo S
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511156
[TBL] [Abstract][Full Text] [Related]
17. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
[TBL] [Abstract][Full Text] [Related]
18. Effects of prenatal exposure to valproic acid or poly(I:C) on ultrasonic vocalizations in rat pups: The role of social cues.
Potasiewicz A; Gzielo K; Popik P; Nikiforuk A
Physiol Behav; 2020 Oct; 225():113113. PubMed ID: 32738314
[TBL] [Abstract][Full Text] [Related]
19. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
Gao MM; Shi H; Yan HJ; Long YS
J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
